Solvent effect on the synthesis of clarithromycin: A molecular dynamics study

Clarithromycin (6-O-methylerythromycin A) is a 14-membered macrolide antibiotic which is active in vitro against clinically important gram-positive and gram-negative bacteria. The selectivity of the methylation of the C-6 OH group is studied on erythromycin A derivatives. To understand the effect of the solvent on the methylation process, detailed molecular dynamics (MD) simulations are performed in pure DMSO, pure THF and DMSO:THF (1:1) mixture by using the anions at the C-6, C-11 and C-12 positions of 2′,4′′-[O-bis(TMS)]erythromycin A 9-[O-(dimethylthexylsilyl)oxime] under the assumption that the anions are stable on the sub-nanosecond time scale. The conformations of the anions are not affected by the presence of the solvent mixture. The radial distribution functions are computed for the distribution of different solvent molecules around the `O−' of the anions. At distances shorter than 5 Å, DMSO molecules are found to cluster around the C-11 anion, whereas the anion at the C-12 position is surrounded by the THF molecules. The anion at the C-6 position is not blocked by the solvent molecules. The results are consistent with the experimental finding that the methylation yield at the latter position is increased in the presence of a DMSO:THF (1:1) solvent mixture. Thus, the effect of the solvent in enhancing the yield during the synthesis is not by changing the conformational properties of the anions, but rather by creating a suitable environment for methylation at the C-6 position.

[1]  T. Adachi,et al.  Chemical modification of erythromycins. IX. Selective methylation at the C-6 hydroxyl group of erythromycin A oxime derivatives and preparation of clarithromycin. , 1993, The Journal of antibiotics.

[2]  J. Dannenberg,et al.  Effect of Basis Set Superposition Error (BSSE) upon ab Initio Calculations of Organic Transition States , 2001 .

[3]  F M Richards,et al.  Areas, volumes, packing and protein structure. , 1977, Annual review of biophysics and bioengineering.

[4]  C. Baysal,et al.  Modeling the selective methylation in the synthesis of clarithromycin , 2002 .

[5]  C. Baysal,et al.  A computational approach to the synthesis of dirithromycin , 2004, Journal of molecular modeling.

[6]  A. Longo,et al.  A new convenient transformation of erythromycin A into clarithromycin. , 1999, Bioorganic & medicinal chemistry.

[7]  G. van Rooyen,et al.  Sensitive liquid chromatography-tandem mass spectrometry method for the determination of clarithromycin in human plasma. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[8]  T. Adachi,et al.  Chemical modification of erythromycins. XII. A facile synthesis of clarithromycin (6-O-methylerythromycin A) via 2'-silylethers of erythromycin A derivatives. , 1993, The Journal of antibiotics.

[9]  F. Schluenzen,et al.  Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria , 2001, Nature.

[10]  H. Meirovitch,et al.  Ab initio prediction of the solution structures and populations of a cyclic pentapeptide in DMSO based on an implicit solvation model , 2000, Biopolymers.

[11]  T. Adachi,et al.  Chemical modification of erythromycins. II. Synthesis and antibacterial activity of O-alkyl derivatives of erythromycin A. , 1990, The Journal of antibiotics.

[12]  Yoshiaki Watanabe,et al.  Chemical modification of erythromycins. VIII, A new effective route to clarithromycin (6-O-methylerythromycin A) eng , 1990 .

[13]  C. Brooks Computer simulation of liquids , 1989 .

[14]  S. Omura,et al.  Chemical modification of erythromycins. III. In vitro and in vivo antibacterial activities of new semisynthetic 6-O-methylerythromycins A, TE-031 (clarithromycin) and TE-032. , 1990, The Journal of antibiotics.

[15]  L. Verlet Computer "Experiments" on Classical Fluids. I. Thermodynamical Properties of Lennard-Jones Molecules , 1967 .

[16]  H. C. Andersen Molecular dynamics simulations at constant pressure and/or temperature , 1980 .

[17]  M. Sironi,et al.  New basis set superposition error free ab initio MO-VB interaction potential: Molecular-dynamics simulation of water at critical and supercritical conditions , 1998 .

[18]  Martin Saunders,et al.  Conformations of cycloheptadecane. A comparison of methods for conformational searching , 1990 .

[19]  H. Meirovitch,et al.  Free energy based populations of interconverting microstates of a cyclic peptide lead to the experimental NMR data. , 1999, Biopolymers.

[20]  Michael D. Burkart,et al.  Biomimetic synthesis and optimization of cyclic peptide antibiotics , 2002, Nature.

[21]  R. Egan,et al.  Acid degradation of erythromycin A and erythromycin B , 1971, Experientia.

[22]  J. Banavar,et al.  Computer Simulation of Liquids , 1988 .

[23]  R. Brennan,et al.  The conformations of the macrolide antibiotics erythromycin A, azithromycin and clarithromycin in aqueous solution: a 1H NMR study , 2000 .

[24]  S. F. Boys,et al.  The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errors , 1970 .

[25]  Hagai Meirovitch,et al.  A free energy based Monte Carlo minimization procedure for biomolecules , 1994 .

[26]  P. J. Atkins,et al.  Kinetic studies on the decomposition of erythromycin A in aqueous acidic and neutral buffers , 1986 .

[27]  D. Osguthorpe,et al.  Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase‐trimethoprim, a drug‐receptor system , 1988, Proteins.

[28]  P. Luger,et al.  Molecular structure of 9-deoxy-11-deoxy-9-11-(imino(2-(2-methoxyethoxy)ethylidene)oxy)-(9S)-erythromycin, a new erythromycin derivative , 1979 .

[29]  T. Adachi,et al.  [Research and development of clarithromycin]. , 1992, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[30]  Yoshiaki Watanabe,et al.  Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A. , 1984, The Journal of antibiotics.